Clinical iterative model development improves knowledge-based plan quality for high-risk prostate cancer with four integrated dose levels.
Johanna Austrheim HundvinKristine FjellangerHelge Egil Seime PettersenBritt NygaardKari RevheimTurid Husevåg SulenChristian EkangerLiv Bolstad HysingPublished in: Acta oncologica (Stockholm, Sweden) (2020)
KBP improved plan quality and consistency among treatment plans for high-risk prostate cancer. Model tuning using KBP-based clinical plans further improved model outcome.